It demonstrated that treatment with metronidazole did not increase the frequency of any congenital malformation diagnosed at birth OR 1.08: 0.90–1.29 95% CI 119 level of evidence: very low. No studies were found which evaluated the safety of using tynidazole during pregnancy.
Se demostró que el tratamiento con metronidazol no incrementa la frecuencia de cualquier malformación congénita diagnosticada al momento del nacimiento OR = 1,08; IC 95%: 0,90-1,29 119 Nivel de evidencia: muy bajo.